FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Emmanouil Xylouris, MD, discusses a poster exploring the clinical safety and efficacy of the fixOflex endocapsular implant.
In a study, a group of patients undergoing standard cataract surgery was compared with a group of patients receiving the fixOflex device (Eye PCR). Postoperative outcomes at 6 months were evaluated.
IOP, endothelial cell count and visual outcomes were comparable, “but we also observed better numbers in terms of decentration of the IOL,” Xylouris said. Only 7% of patients